ACUTAAS.BO Earnings — Acutaas Chemicals Limited
BSE
Updated
When is ACUTAAS.BO's next earnings date?
Acutaas Chemicals Limited (ACUTAAS.BO) has not announced its next earnings date yet. Its most recent earnings report was on Tuesday, October 27, 2026.
How did ACUTAAS.BO do in its last earnings report?
In its most recent report on Oct 27, 2026, Acutaas Chemicals Limited posted EPS of $15.10 versus the $11.07 estimate, a beat. Revenue was $4.37B against a $3.74B estimate.
How much does ACUTAAS.BO stock move after earnings?
ACUTAAS.BO beat EPS estimates in 1 of its last 2 reported quarters.
About Acutaas Chemicals Limited
Headquartered in Surat, India, Acutaas Chemicals Limited, founded in 2004, operates internationally in the research, development, manufacturing, and distribution of pharmaceutical intermediates. These essential chemical building blocks are vital for both regulated and generic active pharmaceutical ingredients (APIs), serving a broad spectrum of medical uses, including treatments for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant conditions. Beyond its pharmaceutical focus, the firm also produces a varied portfolio of specialty chemicals for applications in battery technology, personal care, agrochemicals, protective coatings, electronics, and numerous industrial processes. Furthermore, its offerings include photoresist chemicals crucial for semiconductor production, electrolyte additives for lithium battery cells, and general-purpose chemicals like parabens and methyl salicylate for the cosmetics, agrochemical, and fine chemical industries. The entity, formerly trading as Ami Organics Limited, is scheduled to formally adopt the name Acutaas Chemicals Limited in May 2025.
🤖 AI Earnings Analysis
ACUTAAS.BO trades at a steep 71× P/E despite a strong 26.6% profit margin; without news or growth guidance, that valuation leaves limited room for disappointment.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | 11.07 | 15.10 | — | $4.37B | ✅ Beat | — | — | — | |
| 2026-07-24 | 9.35 | 9.07 | — | $3.30B | ❌ Miss | — | — | — |
Showing last 2 quarters.